| | |
| | |
| Clinical data | |
|---|---|
| Other names | Metheptazine |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C16H23NO2 |
| Molar mass | 261.365 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Metheptazine is an opioid analgesic from the phenazepane family. It was developed by American Home Products in the 1950s. [1]
Metheptazine produces similar effects to other opioids, including analgesia, sedation, dizziness and nausea.
Metheptazine is not listed as a controlled substance under the Controlled Substances Act 1970 in the United States. [2] The Canadian Controlled Drugs and Substances Act specifically excludes the phenazepine opioids metheptazine, ethoheptazine, and metethoheptazine from control.